Company Filing History:
1 out of 1 
1 out of 4 
1 out of 832,843 Years Active: 2010-2019
Title: Innovations by Robert Coopersmith
Introduction
Robert Coopersmith is an accomplished inventor based in Chestnut Hill, MA. He holds three patents that focus on individualized cancer treatment and methods to address challenges in treating melanoma. His work is significant in the field of oncology, where personalized medicine is becoming increasingly important.
Latest Patents
One of Coopersmith's latest patents involves individualized cancer treatment. This patent describes methods to formulate treatments for individual cancer patients by assessing genomic and/or phenotypic differences between cancer and normal tissues. The results are integrated to identify dysfunctional pathways, which can lead to more effective treatment strategies. Another notable patent addresses the treatment of melanoma in BRAF inhibitor-resistant subjects. This patent outlines methods to treat cancer patients, particularly those with melanoma who have BRAF mutations and have become resistant to BRAF mutant kinase inhibitors. It employs inhibitors of multiple receptor tyrosine kinases and describes methods for identifying pharmaceutical compositions and drugs that will be successful in treating these patients.
Career Highlights
Throughout his career, Coopersmith has made significant contributions to cancer research and treatment methodologies. His innovative approaches have the potential to improve patient outcomes and provide new avenues for therapy in challenging cases.
Collaborations
Coopersmith has collaborated with notable individuals in his field, including Raphael Lehrer and Louis Anthony Tartaglia. These collaborations have likely enriched his research and contributed to the development of his patents.
Conclusion
Robert Coopersmith's work exemplifies the impact of innovation in cancer treatment. His patents reflect a commitment to advancing personalized medicine and addressing the complexities of cancer therapy.